Pdt Partners, LLC Natera, Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 3,779 shares of NTRA stock, worth $409,227. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,779

Previous 12,093 68.75%

Holding current value

$409,227

Previous $757,000 54.43%

% of portfolio

0.03%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$59.21 - $92.9 $492,271 - $772,370	-8,314 Reduced 68.75%	3,779 $345,000
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $1.49 Million - $2.49 Million	-39,722 Reduced 76.66%	12,093 $757,000
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $1.39 Million - $2 Million	31,915 Added 160.38%	51,815 $2.29 Million
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $121,843 - $142,754	2,588 Added 14.95%	19,900 $968,000
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $633,099 - $1.01 Million	17,312 New	17,312 $961,000

Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $300,428 - $475,687	10,680 Added 23.63%	55,880 $1.98 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $545 - $1,643	-18 Reduced 0.04%	45,200 $1.84 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $1.01 Million - $1.39 Million	-11,717 Reduced 20.58%	45,218 $4.22 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $1,101 - $1,389	11 Added 0.02%	56,935 $6.35 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $166,420 - $231,538	-1,934 Reduced 3.29%	56,924 $6.46 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $1.76 Million - $2.39 Million	-19,206 Reduced 24.6%	58,858 $5.98 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $888,977 - $1.49 Million	-13,336 Reduced 14.59%	78,064 $7.77 Million
Q3 2020 Nov 16, 2020	SELL	$45.89 - $72.67 $904,033 - $1.43 Million	-19,700 Reduced 17.73%	91,400 $6.6 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $115,404 - $218,287	4,378 Added 4.1%	111,100 $5.54 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $335,469 - $780,302	19,425 Added 22.25%	106,722 $3.19 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $737,369 - $928,028	22,971 Added 35.71%	87,297 $2.94 Million
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $383,897 - $527,746	15,126 Added 30.74%	64,326 $2.11 Million
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $781 - $1,213	-44 Reduced 0.09%	49,200 $1.36 Million
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $558,426 - $1.02 Million	49,244 New	49,244 $1.02 Million
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $1.11 Million - $2.2 Million	-90,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $602,635 - $927,328	32,021 Added 54.94%	90,300 $2.16 Million
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $140,437 - $319,220	15,977 Added 37.77%	58,279 $1.1 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $11.95 $115,335 - $153,139	-12,815 Reduced 23.25%	42,302 $392,000
Q4 2017 Feb 14, 2018	SELL	$8.99 - $14.31 $158,071 - $251,612	-17,583 Reduced 24.19%	55,117 $496,000
Q3 2017 Nov 14, 2017	BUY	$8.02 - $13.33 $583,054 - $969,091	72,700	72,700 $937,000

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account